Hims & Hers Health, INC Form 4 insider transactions

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported the sale of 4,153 shares of Class A Common Stock on February 3, 2025, at a price of $35.3 per share.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed a stock option exercise and subsequent sale of 17,304 Class A Common shares on January 24, 2025.

Hims & Hers CEO Andrew Dudum exercised stock options and sold shares on January 23, 2025, according to a recent SEC filing.

Boughton Soleil, Chief Legal Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on January 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock option exercises and sales under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum exercised stock options of Hims & Hers Health, Inc. under a pre-arranged 10b5-1 trading plan.

Hims & Hers CEO Andrew Dudum exercised stock options and sold a portion of his holdings in Class A Common Stock on January 16, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 10, 2025, according to a Form 4 filing.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 2, 2025, according to a Form 4 filing with the SEC.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports exercising stock options to acquire Class A Common Stock.

Hims & Hers Health, Inc. CFO, Oluyemi Okupe, sold 4,213 shares of Class A Common Stock at an average price of $29.9829 per share on December 26, 2024, under a pre-arranged 10b5-1 trading plan.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. on December 24, 2024, according to a Form 4 filing.

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CFO Oluyemi Okupe sold shares of Class A Common Stock on December 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers CEO Andrew Dudum amended a previous SEC filing to accurately reflect his share transactions and holdings, including sales, acquisitions, and indirect ownership through various trusts.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed multiple transactions involving Class A Common Stock and Restricted Stock Units, including acquisitions, disposals, and tax withholdings.

Director David B. Wells of Hims & Hers Health, Inc. acquired 10,046 shares of Class A Common Stock and vested in 10,046 Restricted Stock Units on December 13, 2024.

Irene Becklund, a Principal Accounting Officer at Hims & Hers Health, Inc., reported multiple transactions involving Class A Common Stock and Restricted Stock Units.

Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, reported the acquisition of 12,988 shares and the disposal of 5,387 shares to cover tax obligations related to vesting of restricted stock units.

Hims & Hers Health's Chief Legal Officer, Soleil Boughton, reported the acquisition of 43,209 shares and the disposal of 23,751 shares of Class A Common Stock on December 13, 2024, along with the vesting of multiple Restricted Stock Units.

Hims & Hers Health, Inc. CFO Oluyemi Okupe reports the acquisition and disposal of company stock and restricted stock units on December 13, 2024.

Chief Operating Officer of Hims & Hers Health, Melissa Baird, reports the acquisition and disposal of company stock and restricted stock units.

Hims & Hers CEO Andrew Dudum executed multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

A Hims & Hers Health executive exercised stock options and sold shares under a pre-arranged trading plan.